{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:17:28Z","timestamp":1791141448274,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejphar.2011.01.063","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T04:27:10Z","timestamp":1297398430000},"page":"173-183","source":"Crossref","is-referenced-by-count":40,"title":["Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX"],"prefix":"10.1016","volume":"657","author":[{"given":"Margarita T.","family":"Murri-Plesko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzbeta","family":"Hulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Old","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Swietach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.01.063_bb0005","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjc.6605200","article-title":"Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours","volume":"101","author":"Ahlskog","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6604111","article-title":"Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype","volume":"98","author":"Barathova","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0020","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.177.4.2423","article-title":"Structure\u2013activity profiles of Ab-derived TNF fusion proteins","volume":"177","author":"Bauer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0025","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase ix, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0035","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","article-title":"A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies","volume":"274","author":"de Haard","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(07)70044-X","article-title":"Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial","volume":"8","author":"Divgi","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","article-title":"Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression","volume":"18","author":"Fang","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1677\/erc.1.01216","article-title":"Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin\/tamoxifen therapy for breast cancer","volume":"13","author":"Generali","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0060","first-page":"7992","article-title":"Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer","volume":"61","author":"Giatromanolaki","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jmri.10181","article-title":"MRI of the tumor microenvironment","volume":"16","author":"Gillies","year":"2002","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q","article-title":"Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250","volume":"85","author":"Grabmaier","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0075","first-page":"1373","article-title":"Substrate balances across colonic carcinomas in humans","volume":"55","author":"Holm","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.cub.2008.04.049","article-title":"Extracellular acidification elicits spatially and temporally distinct Ca2+ signals","volume":"18","author":"Huang","year":"2008","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0085","first-page":"3759","article-title":"Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts","volume":"49","author":"Kallinowski","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.bjc.6604949","article-title":"Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer","volume":"100","author":"Korkeila","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0095","first-page":"1901","article-title":"Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910380406","article-title":"Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney","volume":"38","author":"Oosterwijk","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0105","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0115","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1073\/pnas.0901425106","article-title":"Rational development of high-affinity T-cell receptor-like antibodies","volume":"106","author":"Stewart-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2011.01.063_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2010.03.015","article-title":"Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy","volume":"58","author":"Stillebroer","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000107550","article-title":"pH nanoenvironment at the surface of single melanoma cells","volume":"20","author":"Stock","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0140","doi-asserted-by":"crossref","first-page":"20473","DOI":"10.1074\/jbc.M801330200","article-title":"Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths","volume":"283","author":"Swietach","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0145","doi-asserted-by":"crossref","first-page":"20299","DOI":"10.1074\/jbc.M109.006478","article-title":"The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths","volume":"284","author":"Swietach","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0150","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","article-title":"Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers","volume":"67","author":"Winter","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0155","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.01.063_bb0160","doi-asserted-by":"crossref","first-page":"e9625","DOI":"10.1371\/journal.pone.0009625","article-title":"Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS ONE"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:06:17Z","timestamp":1559988377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0014299911001221"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.01.063","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}